&Partners’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.87M Sell
12,134
-341
-3% -$129K 0.02% 538
2026
Q1
$3.69M Sell
12,475
-5,350
-30% -$1.49M 0.02% 634
2025
Q4
$3.45M Sell
17,825
-4,663
-21% -$800K 0.02% 630
2025
Q3
$3.1M Buy
22,488
+5,243
+30% +$573K 0.02% 585
2025
Q2
$1.55M Buy
17,245
+1,886
+12% +$151K 0.01% 774
2025
Q1
$1.28M Buy
15,359
+4,258
+38% +$476K 0.01% 722
2024
Q4
$1.45M Buy
11,101
+3,640
+49% +$431K 0.02% 614
2024
Q3
$1M Buy
7,461
+3,012
+68% +$406K 0.02% 572
2024
Q2
$660K Buy
+4,449
New +$565K 0.03% 454

Other funds holding TER

&Partners's TER Position: Q2 2026 in Review

&Partners reduced its Teradyne (TER) stake by 2.7% in Q2 2026, selling an estimated $129K and leaving 12,134 shares worth $5.87M. The position accounts for 0.02% of the portfolio, ranked #538.

&Partners first reported a position in TER in Q2 2024 and has held it in 9 quarters since. 1,424 funds tracked by Wall St. Rank hold TER as of Q2 2026.

  • &Partners held 12,134 shares of Teradyne worth $5.87M as of Q2 2026.
  • &Partners sold 341 Teradyne shares in Q2 2026, an estimated $129K.
  • Teradyne made up 0.02% of &Partners's portfolio in Q2 2026, its #538 holding.
  • &Partners first reported a position in Teradyne in Q2 2024 and has held it in 9 quarters since.
  • 1,424 funds tracked by Wall St. Rank held Teradyne as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.